Ultime notizie per Rapid7 (NASDAQ:RPD) Azioni

Rapid7

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

Rapid7 Inc

Rapid Line Inc

Rapidtron Inc

Morgan Stanley analyst Erin Wilson maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Equal-Weight and lowers the price target from $33 to $26.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $26

Barclays analyst Saket Kalia maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Equal-Weight and lowers the price target from $35 to $26.

Barclays Maintains Equal-Weight on Rapid7, Lowers Price Target to $26

WIIM

ADBE

ADSK

DOCU

ESTC

FIVN

FTNT

GLOB

GWRE

HUBS

INTU

MANH

MSFT

NTNX

ORCL

OTEX

PANW

Shares of companies in the broader software sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

ACIW

AEYE

ANSS

APPF

APPN

NICE

OPRA

QLYS

TEAM

UPLD

YEXT

Shares of software ant IT stocks are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Stephens &amp; Co. analyst Todd Weller initiates coverage on Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Equal-Weight rating and announces Price Target of $33.

Initiation

Stephens & Co. Initiates Coverage On Rapid7 with Equal-Weight Rating, Announces Price Target of $33

Jefferies analyst Joseph Gallo maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Buy and lowers the price target from $45 to $35.

Jefferies Maintains Buy on Rapid7, Lowers Price Target to $35

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>RBC Capital raised Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) price target from $42 to $45. RBC Capital analyst Jonathan Atkin reiterated a Sector Perform rating. Verizon shares closed at $43.56 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/VZ/analyst-ratings">view this stock</a>.</li>
<li>Stephens &amp; Co. cut the price target for Akoya Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) from $3.5 to $1.8. Stephens &amp; Co. analyst Mason Carrico downgraded the stock from Overweight to Equal-Weight. Akoya Biosciences shares closed at $1.67 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/AKYA/analyst-ratings">view this stock</a>.</li>
<li>Morgan Stanley boosted Plains All American Pipeline, L.P. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) price target from $19 to $23. Morgan Stanley analyst Robert Kad maintained an Equal-Weight rating. Plains All American Pipeline shares closed at $20.17 on Monday. <a href="https://www.benzinga.com/quote/PAA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Scotiabank cut the price target for Quanterix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTRX#NASDAQ">QTRX</a>) from $28 to $18. Scotiabank analyst Sung Nam maintained a Sector Outperform rating. Quanterix shares closed at $7.19 on Monday. <a href="https://www.benzinga.com/quote/QTRX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson lowered the price target for Rapid7, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) from $35 to $29. DA Davidson analyst Rudy Kessinger maintained a Neutral rating. Rapid7shares closed at $29.70 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/RPD/analyst-ratings">view this stock</a>.</li>
<li>Canaccord Genuity cut Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) price target from $22 to $21. Canaccord Genuity analyst Austin Moeller maintained a Buy rating. Intuitive Machines shares settled at $9.22 on Monday. <a href="https://www.benzinga.com/quote/LUNR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Cantor Fitzgerald cut Artiva Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTV#NASDAQ">ARTV</a>) price target from $23 to $20. Cantor Fitzgerald analyst Josh Schimmer maintained an Overweight rating. Artiva Biotherapeutics shares closed at $3.91 on Monday. <a href="https://www.benzinga.com/quote/ARTV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>JP Morgan raised Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) price target from $124 to $129. JP Morgan analyst Kian Abouhossein maintained a Neutral rating. Morgan Stanley shares closed at $124.27 on Monday. &nbsp;<a href="https://www.benzinga.com/quote/MS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan boosted the price target for The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) from $605 to $625. JP Morgan analyst Kian Abouhossein maintained an Overweight rating. Goldman Sachs shares settled at $580.10 on Monday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities cut KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) price target from $67 to $62. B of A Securities analyst Rafe Jadrosich maintained a Neutral rating. KB Home shares closed at $61.79 on Monday. <a href="https://www.benzinga.com/quote/kbh/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44472214/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-delivering-high-dividend-yields-4">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Markets

Trading Ideas

AKYA

ARTV

LUNR

QTRX

Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday

DA Davidson analyst Rudy Kessinger maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Neutral and lowers the price target from $35 to $29.

DA Davidson Maintains Neutral on Rapid7, Lowers Price Target to $29

Rapid7 shares are trading higher after the company announced it entered a cooperation agreement with JANA Partners.

The company will appoint three new members to its Board of Directors: Wael Mohamed, Mike Burns and Kevin Galligan. These appointments will expand Rapid7's Board to comprise 11 directors.&nbsp;
JANA Partners will support all of Rapid7's director nominees at its upcoming annual shareholder meeting.

Management

Rapid7, JANA Partners Management Enter Cooperation Agreement

Ratings for Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) were provided by 15 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Rapid7, revealing an average target of $40.2, a high estimate of $46.00, and a low estimate of $33.00. A decline of 9.72% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1742320822_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Rapid7's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Erin Wilson</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$33.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$38.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Fatima Boolani</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$44.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Adam Tindle</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Brian Essex</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$36.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Roger Boyd</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$38.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$35.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$39.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Joseph Gallo</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$45.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Brian Essex</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$42.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Fatima Boolani</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$42.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Rapid7. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Rapid7 compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Rapid7's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Rapid7's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/RPD/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Rapid7 analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Rapid7</h2>
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
<h3>Key Indicators: Rapid7's Financial Health</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Rapid7 showcased positive performance, achieving a revenue growth rate of 5.36% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Rapid7's net margin excels beyond industry benchmarks, reaching -0.68%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Rapid7's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -25.97%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Rapid7's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.09%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 57.49, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

15 Analysts Have This To Say About Rapid7

Morgan Stanley analyst Erin Wilson maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Equal-Weight and lowers the price target from $38 to $33.

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $33

Scotiabank analyst Patrick Colville maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Sector Perform and lowers the price target from $42 to $38.

Scotiabank Maintains Sector Perform on Rapid7, Lowers Price Target to $38

Citigroup analyst Fatima Boolani maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Buy and lowers the price target from $46 to $44.

Citigroup Maintains Buy on Rapid7, Lowers Price Target to $44

Rapid7 shares are trading lower after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 and FY25 guidance below estimates. Also, multiple firms lowered their respective price targets on the stock.

Raymond James analyst Adam Tindle maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Outperform and lowers the price target from $55 to $45.

Raymond James Maintains Outperform on Rapid7, Lowers Price Target to $45

JP Morgan analyst Brian Essex maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Neutral and lowers the price target from $40 to $36.

JP Morgan Maintains Neutral on Rapid7, Lowers Price Target to $36

UBS analyst Roger Boyd maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Buy and lowers the price target from $52 to $45.

UBS Maintains Buy on Rapid7, Lowers Price Target to $45

Stifel analyst Adam Borg maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Hold and lowers the price target from $42 to $38.

Stifel Maintains Hold on Rapid7, Lowers Price Target to $38

Truist Securities analyst Joel Fishbein maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Hold and lowers the price target from $38 to $35.

Truist Securities Maintains Hold on Rapid7, Lowers Price Target to $35

Press Releases

Rapid7 to Report Fourth Quarter and Full Year 2024 Financial Results on February 12

Rapid7 Achieves FedRAMP® In Process Designation

General

Rapid7 Launches New Global PACT Partner Program

Earnings

Rapid7 Announces Fourth Quarter and Full-Year 2024 Financial Results

Rapid7 Delivers Command Platform Innovations to Identify, Prioritize, and Remediate Critical Exposures

Comments

Rapid7

Notizie

Ultime notizie per Rapid7 (NASDAQ:RPD) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO